Exercise Program to Improve Life Quality After Myeloma Treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests whether a 6-month personalized exercise program—done partly at home and partly at a center—can improve quality of life for patients with multiple myeloma (a blood cancer) who are receiving ongoing chemotherapy or targeted drugs. The program is tailored to your abilities and fits into your regular hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Recently diagnosed with multiple myeloma or experiencing a relapse (cancer returning), and over 60 years old
- Started a new line of treatment within the last 3 months (your 1st, 2nd, 3rd, or 4th treatment plan)
- Receiving ongoing systemic treatment (chemotherapy or drugs) with hospital visits at least twice monthly for the first 3 months, then at least once monthly after that
- Able to speak and understand French
- No severe heart problems related to amyloidosis (abnormal protein buildup)
- Cleared by your doctor to safely do physical activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lifestyle program with exercise and nutrition guidance for people who have had multiple myeloma for at least one year. The goal is to see if it helps improve daily wellbeing and strength.
This trial tests whether a supervised resistance (strength-building) exercise program is safe and beneficial for people with multiple myeloma who are currently receiving treatment. If you have not been exercising regularly, this study could help you improve your strength and well-being.
This study looks at whether controlled breathing exercises can help your heart and lungs during multiple myeloma treatment. You'll do guided breathing sessions at home while your health is monitored remotely.
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
This study looks at how multiple myeloma and its treatment affect the daily life, well-being, and social activities of patients and their caregivers. It aims to understand what factors influence their quality of life.
This trial tests whether a prehabilitation program using adapted physical activity can help multiple myeloma patients prepare for a stem cell transplant. It may improve your strength and recovery before and after the transplant.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.